Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolism and disposition of zamicastat in rats.
Araújo F, Dória ML, Beliaev A, Kiss LE, Bonifácio MJ, Holenz J, Soares-da-Silva P, Loureiro AI. Araújo F, et al. Among authors: bonifacio mj. Xenobiotica. 2024 Oct 10:1-12. doi: 10.1080/00498254.2024.2411993. Online ahead of print. Xenobiotica. 2024. PMID: 39359020
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.
Armenia D, Carioti L, Micheli V, Bon I, Allice T, Bonura C, Bruzzone B, Bracchitta F, Cerutti F, Giammanco GM, Stefanelli F, Bonifacio MA, Bertoli A, Vatteroni M, Ibba G, Novazzi F, Lipsi MR, Cuomo N, Vicenti I, Ceccherini-Silberstein F, Rossetti B, Bezenchek A, Saladini F, Zazzi M, Santoro MM; Italian HIV NGS network and the ARCA Cohort. Armenia D, et al. Among authors: bonifacio ma. Viruses. 2024 Sep 6;16(9):1422. doi: 10.3390/v16091422. Viruses. 2024. PMID: 39339898 Free PMC article.
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network.
Breccia M, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, Sorà F, Soverini S, Messina M, Piciocchi A, Bonifacio M, Cilloni D, Iurlo A, Martinelli G, Rosti G, Stagno F, Fazi P, Vignetti M, Pane F. Breccia M, et al. Among authors: bonifacio m. Clin Lymphoma Myeloma Leuk. 2024 Sep 7:S2152-2650(24)01802-0. doi: 10.1016/j.clml.2024.08.009. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39322541
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.
Bucelli C, Capodanno I, Miggiano MC, Cavazzini F, Crescenzi SL, Russo S, Carmosino I, Annunziata M, Sorà F, Bonifacio M, Luciano L, Caocci G, Loglisci G, Elena C, Lunghi F, Mullai R, Attolico I, Binotto G, Crisà E, Sportoletti P, Di Veroli A, Scortechini AR, Leporace AP, Maggi A, Crugnola M, Stagno F, Sancetta R, Murgano P, Rapezzi D, Luzi D, Vincelli DI, Galimberti S, Bocchia M, Fava C, Malato A, Abruzzese E, Saglio G, Specchia G, Breccia M, Iurlo A, Tiribelli M, Latagliata R. Bucelli C, et al. Among authors: bonifacio m. Eur J Haematol. 2024 Sep 12. doi: 10.1111/ejh.14299. Online ahead of print. Eur J Haematol. 2024. PMID: 39263855
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Among authors: bonifacio m. Haematologica. 2024 Aug 15. doi: 10.3324/haematol.2024.285638. Online ahead of print. Haematologica. 2024. PMID: 39157875 Free article.
Efficacy and safety of intense pulsed light in rosacea: A systematic review.
Martignago CCS, Bonifacio M, Ascimann LT, Vassão PG, Parisi JR, Renno AP, Garcia LA, Ribeiro DA, Renno ACM. Martignago CCS, et al. Among authors: bonifacio m. Indian J Dermatol Venereol Leprol. 2024 Sep-Oct;90(5):599-605. doi: 10.25259/IJDVL_1029_2022. Indian J Dermatol Venereol Leprol. 2024. PMID: 39152889 Free article.
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study.
Palandri F, Elli EM, Morsia E, Benevolo G, Tiribelli M, Beggiato E, Bonifacio M, Farina M, Martino B, Caocci G, Pugliese N, Tieghi A, Crugnola M, Binotto G, Cavazzini F, Abruzzese E, Iurlo A, Isidori A, Bosi C, Guglielmana V, Venturi M, Dedola A, Loffredo M, Fontana G, Duminuco A, Moioli A, Tosoni L, Scalzulli E, Cattaneo D, Lemoli RM, Cilloni D, Bocchia M, Pane F, Heidel FH, Vianelli N, Cavo M, Palumbo GA, Branzanti F, Breccia M. Palandri F, et al. Among authors: bonifacio m. Cancer. 2024 Jul 30. doi: 10.1002/cncr.35489. Online ahead of print. Cancer. 2024. PMID: 39078647
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal.
Tanasi I, Crosera L, Taus F, Orsolini G, Adami G, Olivieri F, Bernardelli A, Bonadonna P, Nalin F, Sella S, Giannini S, Liu Y, Mannelli F, Vanderwert F, Bonifacio M, Krampera M, Rossini M, Lyons JJ, Zanotti R. Tanasi I, et al. Among authors: bonifacio m. Bone. 2024 Sep;186:117141. doi: 10.1016/j.bone.2024.117141. Epub 2024 May 31. Bone. 2024. PMID: 38823568
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
330 results